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Abstract
Background: Patellofemoral pain (PFP) is a common cause of knee pain in adolescents, but there are limited
evidence-based treatment options for this population. Foot orthoses can improve pain and function in adults with
PFP, and may be effective for adolescents. The primary aim of this study is to determine the feasibility of
conducting a full-scale randomised controlled trial (RCT) evaluating the effects of contoured foot orthoses on knee
pain severity and patient-perceived global change, compared to flat shoe insoles, in adolescents with PFP. The
secondary aim is to provide an estimate of treatment effects for foot orthoses, compared to flat insoles, in
adolescents with PFP.
Methods: This randomised, controlled, participant- and assessor-blinded, feasibility trial has two parallel groups.
Forty adolescents (aged 12–18 years) with clinical symptoms of PFP will be recruited from Queensland, Australia.
Participants will be randomised to receive either prefabricated contoured foot orthoses or flat shoe insoles. Both
interventions will be fit by a physiotherapist, and worn for 3 months. Feasibility will be evaluated through assessing
willingness of volunteers to enrol, number of eligible participants, recruitment rate, adherence with the study
protocol, adverse effects, success of blinding, and drop-out rate. Secondary outcomes will evaluate knee-related
pain, symptoms, function, quality of life, global rating of change, patient acceptable symptom state, and use of co-
interventions, at 6 weeks and 3months. Primary outcomes will be reported descriptively, while estimates of
standard deviation and between-group differences (with 95% confidence intervals) will be reported for secondary
outcomes.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: n.collins1@uq.edu.au
1Division of Physiotherapy, School of Health and Rehabilitation Sciences, The
University of Queensland, Brisbane, Queensland 4072, Australia
2La Trobe Sport and Exercise Medicine Research Centre, School of Allied
Health, Human Services and Sport, College of Science, Health and
Engineering, La Trobe University, Melbourne, Victoria, Australia
Full list of author information is available at the end of the article
O’Sullivan et al. Journal of Foot and Ankle Research           (2020) 13:50 
https://doi.org/10.1186/s13047-020-00417-9
(Continued from previous page)
Discussion: Findings of this study will inform the feasibility of a full-scale RCT investigating the efficacy of
contoured foot orthoses in adolescents with PFP. This full-scale study is necessary to improve the evidence base for
management of adolescent PFP, and enhance outcomes for this population.
Trial registration: ACTRN12619000957190.
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Background
Knee pain is responsible for considerable health impact
in adolescents, with patellofemoral pain (PFP) one of the
most common knee pain conditions affecting this popu-
lation [1]. PFP affects almost 30% of adolescents [2], and
can have substantial detrimental effects. These include
reduced participation in sport and physical activity,
which can have implications for general health, mental
health and overall quality of life [3–5]. Paellofemoral
pain in adolescents tends to be persistent [5], with one-
quarter of adolescents experiencing ongoing PFP symp-
toms well into adulthood [6]. Together, this highlights
the importance of optimal management of PFP in ado-
lescents, to avoid ongoing symptoms and disability
across the lifespan.
Despite the burden of adolescent PFP, very few studies
have investigated treatments for this population. Only
two randomised controlled trials (RCTs) have been con-
ducted in adolescents with PFP, which evaluated exercise
and patient education [7], and soft foot orthoses [8].
Due to the lack of direct evidence, clinicians involved in
the management of adolescents with PFP tend to apply
treatment guidelines based on evidence from adult stud-
ies [9]. However, adolescents are a unique population
with their own physical and psychosocial characteristics
[10] – they are not simply small adults. For example, ad-
olescents with PFP do not demonstrate the same quadri-
ceps and hip strength deficits as adults with PFP [10],
especially in early adolescence (age 12–16 years) [11].
Evidence-based treatments evaluated in adult PFP co-
horts may have different efficacy in adolescents with
PFP. While successful outcomes with exercise therapy
and multimodal physiotherapy (exercise combined with
patellar taping and manual therapy) are observed in 62–
81% of adults with PFP after 12 months [12, 13], only
38% of adolescents with PFP experience a successful
outcome with a similar intervention [7, 10]. Adolescents
with PFP also have lower success with exercise therapy
(53%) compared to adults (67%) [10]. Poorer outcomes
in adolescents could be attributable to lower adherence
with home exercise programs [10]. There are a number
of potential barriers to exercise adherence in adoles-
cents, including competing priorities (e.g. school, sport
and social commitments) and the high prevalence of bi-
lateral PFP (which doubles exercise dose/time) [10].
Foot orthoses may be an effective intervention for ado-
lescents with PFP. Worn bilaterally, foot orthoses have
the potential to exert biomechanical and physiological
effects on the lower limb during weight bearing activ-
ities, which typically aggravate PFP [14]. Foot orthoses
are a recommended intervention for adults with PFP [9].
In our previous RCT, prefabricated contoured foot orth-
oses resulted in significantly greater global improvement
than flat insoles over 6 weeks (number needed to treat 4,
95% CI 2 to 51) [12]. Compared to flat insoles, foot orth-
oses resulted in faster symptom improvement in adults
with PFP, which is important given that symptom sever-
ity and duration are key determinants of long-term prog-
nosis [15, 16]. Investigating the efficacy of foot orthoses
in an adolescent population is needed to inform clinical
guidelines specifically for adolescents with PFP.
Considering the expense and time required to run a
full scale RCT, it is necessary to first determine feasibil-
ity. There has been only one previous RCT assessing the
effects of foot orthoses in adolescents with PFP, pub-
lished in 1993 [8]. The results demonstrated a greater
reduction in PFP symptoms with soft foot orthoses and
an exercise program, compared to flat shoe inserts and
exercise. However, the results should be considered with
caution given that the method of foot orthoses prescrip-
tion does not reflect current clinical practice [17], that
only females were included in the study cohort, and the
small sample size (n = 20).
The primary objective of this study is to determine the
feasibility of conducting a full-scale RCT evaluating ef-
fects of contoured, prefabricated foot orthoses on knee
pain severity and patient-perceived global change, com-
pared to flat insoles, in adolescents with PFP. The sec-
ondary objective is to provide an estimate of treatment
effects for prefabricated foot orthoses, compared to flat
insoles, in adolescents with PFP.
Methods
Experimental design
HAPPi Kneecaps! (sHoe inserts for Adolescents with
Patellofemoral PaIn) is a randomised, controlled, partici-
pant- and assessor-blind, feasibility trial, with two paral-
lel groups. The study design was developed in
consultation with the SPIRIT 2013 statement [18] and
the CONSORT 2010 statement extension to randomised
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pilot and feasibility trials [19]. Ethics approval was ob-
tained through The University of Queensland’s Human
Research Ethics Committee (HREC No. 2018000159).
The trial was prospectively registered on the Australia
New Zealand Clinical Trials Registry (ACTR
N12619000957190; date registered 08/07/2019). Written
informed consent will be obtained from all participants
prior to participation in the study.
Participants
Adolescent volunteers with a clinical diagnosis of PFP
will be recruited from the community in Brisbane,
Australia. We will use an active, targeted, comprehensive
recruitment strategy across multiple platforms. This
strategy will integrate successful methods from our pre-
vious patellofemoral RCTs [12, 20, 21], tailored to an
adolescent population. The recruitment strategy will in-
clude: (i) social media: we will target key social media
platforms used by adolescents and their parents, using
free and paid advertising (e.g. Facebook, Twitter); (ii)
secondary schools (private/public) and sports clubs (e.g.
netball, football, athletics) will be provided with recruit-
ment and educational resources on PFP; (iii) community
events: we will target key events attended by adolescents
and their parents (e.g. weekend markets, community
fairs) with flyers and sandwich boards. We will also re-
cruit from our existing databases of PFP volunteers, and
through contacts with health clinics (e.g. general
practitioners).
Sample size has not been formally calculated for this
feasibility study. Based on previous work [22, 23], we es-
timated that 20 participants per group (n = 40) would
allow observation of recruitment practicalities, accept-
ability and common adverse effects of the interventions,
dropouts, and sample variability.
Male and female adolescent volunteers will be eligible
for inclusion if they meet the following criteria: (i) aged
12–18 years; (ii) anterior knee pain of non-traumatic ori-
gin that is rated at least 3 on an 11-point numerical rat-
ing scale (0 = no pain, 10 =maximal pain); (iii) knee pain
aggravated by activities that load the PFJ (e.g. squatting,
stair climbing, running, jumping); (iv) knee pain present
at some time during most weeks; and (v) knee pain of at
least 2 months duration.
Volunteers will be excluded if they meet any of the fol-
lowing criteria: (i) concomitant pain at sites other than
the anterior knee (e.g. other knee structures, hip, lumbar
spine); (ii) history of knee, hip or spine surgery, or other
suspected knee joint pathology (e.g. Osgood Schlatter’s
Disease); (iii) planned lower limb surgery (e.g. arthros-
copy); (iv) recent treatment for PFP (e.g. knee injections
or physiotherapy within the previous 3 months; foot
orthoses within the previous 12 months); or (v) any foot
condition precluding the use of foot orthoses.
Study procedures
After undergoing preliminary screening for eligibility cri-
teria via email and/or telephone, participants will be in-
vited to undergo physical screening at The University of
Queensland to confirm the presence of PFP, and absence
of other anterior knee pain conditions (e.g. Osgood
Schlatter’s Disease, patellar tendinopathy) (Fig. 1). Eligible
volunteers (and/or their parent/guardian) will then pro-
vide written informed consent prior to collection of base-
line measures. All screening procedures and baseline data
collection will be performed by a registered physiotherap-
ist (ICO), from whom group allocation will be concealed.
Participants will be randomised to one of two inter-
ventions: (i) prefabricated contoured foot orthoses, or
(ii) flat shoe insoles. Randomisation procedures will be
via concealed allocation, with the randomisation se-
quence held by an offsite investigator (KTO). Due to the
nature of the two shoe insert interventions (contoured
vs. flat inserts), it is not possible for study physiothera-
pists to be blinded to group allocation. Primary out-
comes for feasibility will be collected by a blinded
assessor (ICO). Secondary outcomes will be self-
reported by participants, who are considered assessors.
To facilitate blinding of participants (and therefore as-
sessors of secondary outcomes) via limited disclosure,
participants will be informed that they will be rando-
mised to one of two shoe insert interventions, and will
not be informed of the differences between the two in-
serts or the study hypotheses [12, 20].
Interventions
The interventions will be fit by a registered physiother-
apist working in a private Physiotherapy clinic in the
greater Brisbane region. Study physiotherapists will be
trained in fitting procedures, which will follow estab-
lished algorithms [20]. Participants will receive up to
four pairs of inserts fit to their daily shoes (e.g. school
shoes, sports shoes, casual shoes). The inserts will be fit-
ted to the participants’ shoes that accommodate foot
orthoses and provide the best support. Fitting proce-
dures for both the contoured and flat shoe inserts will
be based on comfort, to maximise wear time and poten-
tial therapeutic effects. Participants will attend up to
three appointments with the study physiotherapist to en-
sure adequate comfort of the inserts, and will receive
written instructions for using and adapting to the in-
serts. Participants will be asked to wear their inserts as
much as possible during their waking hours, and encour-
aged to transfer the inserts between different shoes as
required to maximise wear time. This is consistent with
current clinical practice. Participants in both groups
will also receive general information and advice about
PFP and activity in a participant handbook (see
Additional file 1).
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Prefabricated contoured foot orthoses
Participants randomised to the contoured foot orthoses
group will receive commercially available prefabricated
foot orthoses (Vasyli Medical, Labrador, Australia)
(Fig. 2). These will be from the same range as the foot
orthoses prescribed in our previous RCT in adults with
PFP [12]. These orthoses are manufactured from
ethylene-vinyl acetate (EVA) with options of a high
(hard, Shore A 70°), medium (Shore A 55°) and low (soft,
Shore A 45°) density, and have an inbuilt arch support
and varus wedging. Modifications will be made to the
foot orthoses to achieve a comfortable fit, via the
addition of wedges or heat moulding as per our pub-
lished algorithm [20].
Flat shoe insoles
Participants randomised to this group will receive flat
shoe inserts manufactured from high density EVA
(Fig. 3). The flat insoles will be of 3 mm uniform thick-
ness along their length, and have an identical covering
fabric as the contoured foot orthoses. This is to control
for any potential effects of the arch contour and wedging
associated with the contoured foot orthoses. As in our
previous RCT, the flat insoles will be described to
participants as an intervention to enhance sensory feed-
back [20]. Following our fitting algorithm [20], the flat
insoles will be heat moulded to enhance comfort as
indicated.
Adverse events
If participants experience any adverse events during the
study period (e.g. excessive pressure from the shoe in-
serts, blistering, increase in knee pain, onset of new pain
elsewhere), they will be encouraged to report these to
the investigator and/or their study physiotherapist. In
this event, standard clinical practice principles will be
implemented. As required, participants will attend an
additional appointment with their study physiotherapist.
The intervention will be modified for comfort according
to procedures described above. If necessary, the shoe in-
serts will be removed until pain settles and slowly re-
introduced as the participant tolerates. Such events will
be recorded as an adverse event, and participants will be
followed up at regular intervals to monitor changes in
symptoms and to ensure they are progressing suffi-
ciently. If symptoms associated with the adverse event
are unable to be resolved, the intervention will be
ceased.
Fig. 1 Participant flow through the study
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Concomitant care
If participants are taking regular medications (e.g. anti-
inflammatories), they will be permitted to continue this
throughout the study duration. If at any point during the
study they wish to increase or start taking pain management
medication, participants will be encouraged to report this to
the investigator (ICO). At the time of entry into the study,
participants will be asked refrain from commencing new
treatments for their knee pain for the duration of the study
(e.g. therapeutic exercise), and to avoid using other assistive
devices such as knee braces or other footwear interventions
for the study duration. Participants will be asked to report
any use of co-interventions in log books (see Additional file 2).
If at any stage participants are not satisfied with their allo-
cated intervention, they will be encouraged to report this to
the investigator (ICO) for appropriate management.
Fig. 2 Prefabricated contoured foot orthoses
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Outcome assessment
At baseline, demographic and PFP data including age,
sex, weight, height, affected knee, bilaterality of PFP,
symptom duration, and aggravating activities will be
collected. Participants will complete patient-reported
outcome measures at baseline, and at 6 weeks and 3
months post-randomisation. Data collection will
largely be completed via an online platform (RED-
Cap), but participants will have the option to
complete a paper version. For the study duration, par-
ticipants will be asked to keep a daily log (assisted by
their parent/guardian as required) of: activities or
sport completed each day, knee pain severity (rated
on a 10-point numerical rating scale; 0 = no pain,
10 = worst pain imaginable), type of shoes worn that
day, hours spent wearing the footwear and shoe in-
serts, adverse effects associated with the shoe inserts,
medication use, and any other comments (see Add-
itional file 2). Study physiotherapists will record at-
tendance, prescription notes and adverse events
during fitting and follow-up. The primary endpoint is
3 months.
Primary outcomes
The primary outcome is the feasibility of conducting a
full-scale RCT. Feasibility will be assessed by evaluating
the following outcomes.
1. Willingness of participants to enroll in the study
(from recruitment database).
2. Number of eligible volunteers (from recruitment
database).
3. Recruitment rate (from recruitment database).
4. Adherence with allocated intervention and log book
completion (from Study Practitioner notes, and
participant log book).
5. Adverse events (from Study Practitioner notes,
adverse events database and participant log book).
6. Success of blinding (risk of performance and
detection bias) (from Credibility and Expectancy
Questionnaire).
7. Drop-out rate (from trial database).
The following parameters were set to inform feasibil-
ity: (i) a recruitment rate of 1 participant per week; (ii)
minimum adherence with shoe insert wear of 2 h per
day, 5 days a week; and (iii) a drop-out rate of ≤20%.
Credibility and the participant’s expectations of treat-
ment will be evaluated using the Credibility and Expect-
ancy Questionnaire [24]. This will be completed at
baseline, and at the participant’s second visit with the
study physiotherapist (~ 2 weeks post-randomisation).
The Credibility and Expectancy Questionnaire consists
of six items organised into two sections; four items re-
lated to thoughts, and two items related to feelings. A
subsequent study determined that credibility is derived
from the first three thought items, and expectancy de-
rived from the fourth thought question and the two feel-
ing questions [25]. The Credibility and Expectancy
Questionnaire has been administered in adolescent pop-
ulations in previous studies [26, 27].
Secondary outcomes
Secondary outcomes will be collected at baseline, 6
weeks and 3months.
Knee pain severity Participants will be asked to report
their usual and worst pain in the preceding week, as well
as pain with a self-nominated aggravating activity. Pain
severity will be measured using 100 mm visual analogue
scales (where 0 mm = no pain and 100 mm=worse pain
imaginable), which have established reliability and valid-
ity for PFP [28].
Knee injury and Osteoarthritis Outcome Score Child
Version (KOOS-Child) The KOOS-Child assesses five
subscales: pain (9 items), symptoms (7 items), difficulty
during daily activities (17 items), ability to participate in
sport and recreation (7 items), and knee related quality
of life (QoL) (6 items) [29]. Participants respond to each
question using 5-point Likert scales from 0 (no prob-
lems) to 4 (extreme problems). Raw scores are trans-
formed to a 0–100 scale, with 0 representing no knee
problems and 100 representing extreme knee problems.
Fig. 3 Flat shoe insoles (a), and image showing the difference in arch contouring and wedging between the flat insoles and prefabricated
contoured foot orthoses (b)
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KOOS-Child demonstrates good measurement proper-
ties in adolescents with knee conditions [30].
Knee injury and Osteoarthritis Outcome Score –
Patellofemoral subscale (KOOS-PF) Along with
KOOS-Child, participants will complete the KOOS-PF.
This subscale was developed for use in people with PFP
and patellofemoral osteoarthritis, and designed to be
used in conjunction with the five original KOOS sub-
scales [31]. KOOS-PF has 11 items, with identical re-
sponse and scoring parameters as KOOS-Child
(described above). KOOS-PF has adequate measurement
properties in adults with PFP [31], although these have
not yet been evaluated in adolescents.
Global rating of change (GROC) A 7-point Likert scale
will be used to assess GROC at 6 weeks and 12 weeks.
Participants will be asked to respond to the question
‘Overall, how has your knee pain changed since the start
of the study?’, using the following responses: ‘completely
recovered’, ‘strongly recovered’, ‘slightly recovered’,
‘same’, ‘slightly worse’, ‘much worse’, and ‘worse than
ever’. GROC has been used in a previous RCT of adoles-
cents with PFP [7].
Patient acceptable symptom state (PASS) The PASS
evaluates the maximum level of symptoms, beyond
which the participant considers themselves to be well
[32]. Participants will be asked to respond either ‘yes’ or
‘no’ to the following question: ‘Considering all the activ-
ities that you do in your daily life, how well you can do
these activities, and your level of pain, do you think that
your current state is satisfactory?’
Anterior knee pain scale (AKPS) The AKPS contains
13 items related to current knee symptoms and function
[33]. Each item’s response is weighted and summed to
produce an overall score between 0 and 100, where 0 rep-
resents maximal disability and 100 represents no disability.
The AKPS is widely used in studies on PFP, and has estab-
lished reliability and validity in adults with PFP [28].
Youth quality of life – short form (YQOL-SF) The
YQOL-SF is a generic assessment of quality of life in in-
dividuals aged 11–18 years with and without chronic dis-
ease or disability [34]. YQoL-SF version 2 consists of 15
items derived from the perceptual instrument of the
YQOL-R, and assess aspects of sense of self, social rela-
tionships, environment and general quality of life. Partic-
ipants respond to each item on a scale from 0 (not at
all) to 10 (completely or a great deal). Overall trans-
formed scores range from 0 to 100, where the higher
score represents better quality of life.
EuroQol-5D-5L The EQ-5D (EuroQoL) questionnaire
is a generic measure of health-related quality of life,
comprised of five items covering five dimensions: (i) mo-
bility; (ii) self-care; (iii) usual activities; (iv) pain/discom-
fort; and (v) anxiety/depression [35]. Participants will
complete the 5 L version, where each subscale has five
possible responses. Participants will also complete a vis-
ual analogue scale for self-reported health state, where 0
represents worst imaginable health state and 100 repre-
sents the best imaginable health state. We elected to use
the adult version of EQ-5D-5L for this study, rather than
the youth version, as some of our participants will fall
outside the recommended age group for the EQ-5D-Y
(age 8–15 years), and to facilitate comparison with data
collected in previous studies in adolescents with PFP [7].
Use of co-interventions Participants will be asked to
keep a daily record of any use of co-interventions, out-
side their allocated intervention, utilized throughout the
study (e.g. pain medication, physiotherapy, knee brace,
other footwear interventions). This will be recorded in
their log books over the three-month study period.
Data management
Each participant’s information will be coded in a re-
identifiable format, and stored in a database with no
group identifier to maintain blinding of the investigator.
Electronic databases containing participant contact de-
tails will be password protected. All databases will be
stored on a password protected computer. All hard cop-
ies of data will be coded and stored in a locked filing
cabinet in the School of Health and Rehabilitation Sci-
ences at The University of Queensland.
Planned statistical analyses
Descriptive statistics will be calculated for the primary
feasibility outcomes. Estimates of i) standard deviation of
the secondary clinical outcomes, and ii) between-group
differences in secondary clinical outcomes, with accom-
panying 95% confidence intervals, will be calculated.
Post-trial care
If participants experience any adverse events after com-
pletion of the study, they will be referred for follow up
by appropriate health care providers. Participants will be
permitted to keep their intervention after completion.
On request, participants will be provided with additional
shoe inserts on completion of the study (either con-
toured or flat shoe inserts). The contact details of the
primary investigator will be available to each participant
for any concerns related to the study.
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Study exit interview
After study completion, participants will be invited to
partake in a one-on-one semi-structured exit interview.
Questions will be aimed at further exploring aspects of
study feasibility, and credibility and acceptability of
the interventions, and burden of assessment schedule.
Interviews will be conducted by the blinded investiga-
tor (ICO).
Distribution of results
Once completed, study outcomes will be made available
to participants via email or post on request. Outcomes
will be disseminated via peer-reviewed publications, and
submission of abstracts to appropriate national and
international conferences.
Discussion
PFP in adolescents is a problem, with clear implications
for function, quality of life, and future knee health.
Current clinical guidelines for PFP management are
largely based on studies conducted in adults with PFP,
with minimal data available regarding efficacious treat-
ments for adolescents with PFP. Given the significance
and potential impact of PFP in adolescents, it is impera-
tive that we identify interventions that are acceptable
and effective for this specific population. This feasibility
study is the first step in evaluating foot orthoses as an
intervention for adolescents with PFP.
We chose to evaluate prefabricated foot orthoses ra-
ther than custom foot orthoses in adolescents with PFP.
This was based on the greater accessibility and substan-
tially lower costs associated with prefabricated orthoses
compared to custom orthoses [36]. Eng & Pierrynowski
[8] evaluated the effect of medially posted soft foot orth-
oses in 20 adolescent females with bilateral PFP (mean ±
SD age 15 ± 1 years, range 13–17 years). Participants
were randomized to either posted or flat insoles, with
both groups receiving an exercise program. After 8
weeks, the group who received medially posted orthoses
had significantly greater improvements in pain severity
during running, stair ambulation and squatting, com-
pared to the group who received flat insoles. Notably,
significant between-group differences at 8 weeks tended
to exceed the minimal clinically important difference for
pain measured on a visual analogue scale (2 cm) [28].
While this study provides important preliminary infor-
mation regarding the potential effects of foot orthoses
for adolescents with PFP, there have been no further
RCTs in this area since 1993. Furthermore, the soft foot
orthosis prescription used in the study by Eng and Pier-
rynowski [8] likely does not reflect current prescription
practices [17]. Together, this highlights the need for fur-
ther studies in order to support the use of foot orthoses
in adolescents with PFP.
Many adolescents experience bilateral symptoms (70%
versus 43% in adults) [37]. Foot orthoses are typically
worn bilaterally, and thus have potential effects on both
lower limbs during weight bearing activities. This is im-
portant for PFP, in that most aggravating activities involve
weight bearing. Furthermore, because foot orthoses can
be worn during physical activity and exercise (including
therapeutic exercise), they may play a role in relieving pain
and facilitating participation. Importantly, the use of a pas-
sive intervention such as foot orthoses may help to over-
come issues with treatment adherence, which can be a
substantial barrier in adolescents. Foot orthoses require
minimal time or cost in that they are worn in everyday
footwear, and easily transferred from school shoes to
sports shoes. They have minimal side effects (e.g. rubbing
and blistering), and in the case that they do, can be ad-
justed to enhance comfort [12].
This feasibility study is an important initial step in
evaluating the efficacy of foot orthoses for adolescents
with PFP, and has a number of strengths. The study de-
sign adheres to the SPIRIT guidelines [18] and CONSORT
extension for pilot and feasibility studies [19]. Key features
of the study design include randomisation, concealed allo-
cation, and blinded data collection and analysis. The inter-
ventions to be evaluated in this study are simple to
replicate in clinical practice, and are being administered in
the clinical setting by physiotherapists. Secondary out-
come measures that will provide estimates of treatment ef-
fects have been selected based on their applicability for
use in adolescents, as well as their established measure-
ment properties in PFP and, where possible, adolescents.
Conclusion
HAPPi Kneecaps! will determine the feasibility of con-
ducting a full-scale RCT evaluating the effects of foot
orthoses on knee pain severity and patient-perceived
global change, compared to flat insoles, in adolescents
with PFP. Secondary outcomes will provide estimates of
treatment effect sizes for prefabricated foot orthoses,
compared to flat insoles, in this population. Given the
high prevalence and burden of PFP in adolescence, and
potential long-term sequelae, this study is an important
first step in identifying appropriate and efficacious inter-
ventions for this population.
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